Galafold 123 MG
Ended Awarded
- Contract number
- 36C24525N0243
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89 Part of Amicus Therapeutics, Inc.
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $21,089
Award facts
- Contract value 100% obligated
- $21,089.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs (VA) awarded a $21,089.47 firm fixed price delivery order contract to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc. The contract is for the supply of GALAFOLD 123 MG, an enzyme replacement therapy for the treatment of Fabry disease. This delivery order was placed under Amicus Therapeutics US, LLC's Federal Supply Schedule (FSS) contract 36F79724D0185, which has a ceiling value of $13,024,630 and a period of performance through August 31, 2029. The contract supports the VA's mission to provide specialized healthcare services and medications to veterans, ensuring access to treatments for rare diseases like Fabry disease. No set-aside designations were applied to this contract award.
Quick answers
Who was awarded contract 36C24525N0243?
36C24525N0243 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on December 13, 2024.
How much is contract 36C24525N0243 worth?
The government has obligated $21,089 on 36C24525N0243.
Is contract 36C24525N0243 an order under another contract?
Yes. 36C24525N0243 is a delivery order under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0243 competed?
The extent of competition for 36C24525N0243 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award